Recent findings have suggested that the primary factors for development of chronic venous disease (CVD), which commonly manifests as varicose veins (VV), are due to structural and biochemical modifications of the vessel wall. The aim of this exploratory study was to characterize by flow cytometry the endothelial cells (EC) mechanically extracted from the varicose saphenous veins (VSV) segments of patients submitted to VV surgery, and to compare the expression of cell surface molecules in these EC with that observed in the EC from the graft SV (GSV) of patients undergoing bypass surgery. EC were isolated from distal-(varicose trunk) and from proximal-(nearly normal) VSV segments of 30 patients submitted to VV surgery, and from proximal GSV segments of 20 patients submitted to bypass surgery (control group), using a mechanical method, and their immunophenotype was characterized by flow cytometry. EC were identified as being CD45 neg CD146 bright CD31 bright , and analyzed for expression of activation-related (CD54, CD62E, CD106), procoagulant (CD142), and cell junction (CD31, CD146) molecules, and for the scavenger receptor, CD36. The EC harvested from the SV segments of CVD patients had lower expression of all the molecules evaluated, in comparison to controls; these differences were more evident for the EC isolated from the distal-VSV. The EC extracted from the proximal-and distal-VSV segments of the CVD patients also differ from each other, the first having lower levels of CD62E, CD106, CD142 and CD36. Groups did not match for gender and controls were heterogeneous concerning the underlying pathologies, which may have a confounding effect. Our study revealed that the EC isolated from varicose (distal) and nearly normal (proximal) VSV segments of the CVD patients differ phenotypically from each other, and from the EC of the control group. The VSV segments more affected by the CVD have the lowest expression of the studied markers. We hypothesize that CVD is associated with a decrease on the EC surface molecules, causing EC dysfunctionality. Further studies with a large number of gender-matched participants are needed, to confirm the results obtained in this exploratory study.
Introduction
Chronic venous disease (CVD) is a common pathology in the Western adult population with social-economic impact, and the varicose veins (VV) are the most common manifestations of the disease [1] [2] [3] [4] . The prevalence of CVD varies between studies, with values increasing with age and ranging from 15 to 63% in men and 28 to 57% in women [5] [6] [7] [8] [9] . Patients with CVD frequently have dilated, elongated and tortuous veins mainly in the lower limbs, and many of them complain of pain, heaviness, swelling, tingling, cramps, itching, and restless legs, which affect their quality of life [1] .
Although several risk factors for CVD have been recognized, including advanced age, family history, multiple pregnancies, obesity, and prolonged orthostatic posture, its etiology and pathogenesis remain controversial. The theory that prevails attributes the development of VV to the valve incompetence, which causes blood reflux, with subsequent increase of venous pressure, creating venous hypertension, and contributes to the presence of stasis and the hypoxia environment inside the vessels of the lower limbs [1, 2, 10] . These alterations caused by the blood reflux are thought to weaken and dilate the vein walls. However, with the improvement of the imaging techniques is not uncommon to find VV with competent valves, and in the last years, several studies have shown structural and biochemical changes on the vein walls preceding the valve incompetence and resulting in vein weakness and dilation [10] [11] [12] [13] [14] . In addition, several alterations of the extracellular matrix (ECM) have been reported in the VV, such as an increase of collagen type I and a decrease of collagen type III and elastin [13, 15, 16] . These proteins are responsible for conferring vein rigidity, elasticity, and vascular tone, and its disproportion in VV may contribute for the dilation of the vessel walls, loss of the venous tone, and vein thickness and tortuosity [16] [17] [18] . Alterations at the cell level, mainly in respect to the number, organization, and morphology of the smooth muscle cells, have also been described, contributing to an abnormal collagen content and consequently to abnormal contractile features of the veins [12, [18] [19] [20] [21] . Finally, the changes occurring in the vessel walls, progressing from the inside to the outside of the vessels, may also be determined by the endothelial cells (EC) [20, 22] .
Activated EC do express several surface molecules that are absent or expressed at very low levels on resting EC. These include the Intercellular Adhesion Molecule 1 (ICAM-1, CD54), the Vascular Cell Adhesion Molecule 1 (VCAM-1, CD106) and the E-Selectin (CD62E), all together being responsible for the recruitment, adhesion and transmigration of leukocytes from the blood to the inflamed tissues, and for a cascade of events that cause biochemical and structural changes in the inner of the vessel wall [23] [24] [25] . Endothelial cell activation also induces the expression and release of procoagulant molecules, such as the Tissue Factor (CD142), an important initiator of the coagulation cascade [26] . Varicose veins seem to be a risk factor for the development of venous thrombosis, although this point is still controversial [27, 28] . The collagen type I and thrombospondin receptor CD36, a class B scavenger receptor involved in lipid metabolism that plays a role in inflammatory and anti-angiogenic responses, may also be implicated in CVD; in accordance, previous studies have shown an altered CD36 expression on distended SV and on human umbilical vein endothelial cells (HUVEC) exposed to different flow conditions [29, 30] . Moreover, EC are responsible for the release of a variety of molecules that have a key role in vasodilation and vasoconstriction, so their perturbation may affect the venous tone [31, 32] .
Flow cytometry (FCM) is a powerful and well-established method used to characterize the cells from different organs and tissues in diverse clinical settings, as it allows to measure several cell attributes, including cell size and complexity, and surface and intracellular expression of functionally relevant molecules [33, 34] . Although EC seem to have a role in the pathogenesis of the CVD and many studies have used immunohistochemistry to characterize the EC for the expression of several cell molecules, very few studies have used FCM to explore the immunophenotype of the EC in normal and pathological conditions. To explore the role of the endothelium in CVD, we used FCM to characterize the expression of cell junction adhesion, activation-related and procoagulant molecules, and scavenger receptors on the EC extracted from varicose saphenous vein (VSV) segments of patients suffering from CVD, comparatively to the EC harvested from graft saphenous vein (GSV) segments obtained from patients submitted to bypass surgery.
Patients and methods

Study design
This is an exploratory non-interventional FCM-based study, on the expression of relevant surface molecules in the EC extracted from human SV segments by a manual mechanical method.
Two groups of patients undergoing vascular surgery in the Angiology Department of Hospital de Santo António, Centro Hospitalar Universitário do Porto (CHUP), Porto, Portugal, were included: patients suffering from CVD submitted to VV surgery, and patients who underwent bypass surgery using SV grafts (control group). As inclusion criteria in the CVD group, the patients had to have at least the C2 category of the CEAP (Clinical, Etiology, Anatomy, and Pathophysiology) Comprehensive Classification System for Chronic Venous Disorders, with VV in the SV territory. The exclusion criteria for the group submitted to bypass surgery were to have CVD, and, for both groups, to have diabetes mellitus, cancer and infectious diseases.
Patients were selected by convenience sampling, until reaching at least 20 cases in each group. Two SV segments, corresponding to distinct anatomical regions (proximaland distal-VSV), were obtained per CVD patient, whereas in the control group, only one SV segment was collected (proximal-GSV).
At the Laboratory, the EC were isolated from the inner layer of the SV segments using a mechanical method and then analyzed by FCM for the expression of several functionally surface markers.
Ethical issues and study approval
The study proposal was approved by the Hospital´s Scientific and Ethical Committee, and authorized by the Direction board, being registered with the number 2011/049 (031-DEFI/049-CES). All patients received information about the study, and gave the informed consent to participate.
Study population
The CVD group included 30 patients, 23 females and 7 males, with a median age of 55.5 years, ranging from 33 to 76 years, whereas the control group had 20 patients, 5 females and 15 males, with a median age of 61 years, ranging from 29 to 87 years ( Table 1 ). Since most of the patients performing VV surgery are females, whereas most of the patients submitted to bypass surgery are males, and due to difficulties in obtaining SV segments for research, we were unable to match the CVD and control groups for gender. In addition, because of the multiple types of bypass surgeries and their distinct clinical indications, the control group is heterogeneous concerning the associated pathological conditions. In accordance, 12 patients suffered from peripheral arterial disease because of atherosclerosis, and they performed peripheral vascular bypass surgery mainly of the arteries supplying the lower extremities; four patients were renal transplant recipients in whom bypass surgery was part of the vascular reconstruction; and the remaining four patients, performed bypass surgery for exclusion of aneurysms ( Table 1) . Cases of coronary bypass were not included because our hospital does not have cardiac surgery.
Saphenous vein sample collection
Two SV segments were obtained from patients submitted to VV surgery: one corresponding to the distal segment of the VSV (distal-VSV), i.e., trunk varicose veins, having marked wall thickness, tortuosity, and dilation; and another obtained from the VSV near to the saphenous-femoral junction (proximal-VSV, saphenous arc), with macroscopically normal or nearly normal appearance, but physiologically abnormal, i.e., with venous reflux. In patients submitted to bypass surgery with GSV as vascular conduits, only one GSV segment was obtained, near the saphenous-femoral junction (proximal-GSV). These patients were used as controls, since their SV were anatomically and morphologically healthy. The median length of the SV segments was of 2 cm (ranging from 0.4 to 15 cm). The SV segments harvested were placed in a container with saline (0.9% sodium chloride saline solution), and immediately sent to the Laboratory of Cytometry. At the Laboratory, the saline solution was removed, and replaced by phosphate-buffered saline solution (PBS, pH 7.2), containing 2% (w/v) bovine serum albumin (BSA) (PBS-BSA).
Endothelial cell isolation
Endothelial cells were isolated using a mechanical method developed by our group [35] (Fig. 1) . Briefly, the SV segments were open longitudinally with the help of a fine long point scissor, and their extremities were fixed with needles to a styrofoam plate covered with paraffin film (Parafilm ® , Bemis NA, Neenah, Wisconsin), keeping the inner vascular surface facing upwards. The exposed inner vascular surface was maintained hydrated by periodically adding a few drops of PBS-BSA, and the vascular lumen was gently squeezed in continuous movements with two serrated forceps, to release the EC. Next, the cells detached from the SV segment were transferred into a 15 mL conical polypropylene tube using a Pasteur's pipette. The steps of adding PBS-BSA, squeezing the inner layer of the vessel wall and transferring of the cells to the conical tube, were repeated at least five times to assure the maximum recovery of EC. Next, after a resting time of 5-15 min to sediment the debris, the cell suspension was transferred into another 15 mL conical tube, and centrifuged at 300×g for 5 min, at room temperature. After discarding the supernatant, and adding 2 mL of PBS-BSA, the cells were centrifuged again, in the same conditions. Finally, the supernatant was discarded and the cells were suspended in 500 µL of PBS-BSA, being used for cell immunophenotyping.
Endothelial cell immunophenotyping
Endothelial cells were stained using a direct immunofluorescence stain-no-wash technique, as previously described [35] , with monoclonal antibodies (mAbs) conjugated with fluorescein isothiocyanate (FITC), phycoerythrin (PE), peridinin chlorophyll protein (PerCP), allophycocyanin (APC) and violet 450 (V450) ( Table 2 ). These were specific for CD31 (PECAM-1, platelet endothelial cell adhesion molecule 1), CD36 (thrombospondin-1 receptor), CD45 (LCA, leukocyte common antigen), CD54 (ICAM-1, intercellular adhesion molecule 1), CD62E (E-selectin), CD106 (VCAM-1, vascular cell adhesion molecule 1), CD142 (tissue factor), and CD146 (MCAM, melanoma cell adhesion molecule). Briefly, 100 µL of cell suspension with 0.3-2.1 × 10 3 cells/ µL, were transferred into four polypropylene 12 × 75 mm tubes (Falcon ® Round-Bottom Polystyrene tubes, 5 mL, Becton Dickinson, Franklin Lakes, USA) containing the following combination of mAbs-tube 1: anti-CD62E FITC, anti-CD146 PE, anti-CD45 PerCP, and anti-CD31 V450; tube 2: anti-CD36 FITC, anti-CD146 PE, anti-CD45 PerCP, anti-CD106 APC, and anti-CD31 V450; tube 3: anti-CD142 FITC, anti-CD146 PE, anti-CD45 PerCP, anti-CD54 APC, and anti-CD31 V450; and tube 4, without mAbs (unstained cells; negative control). After incubating for 15 min at room temperature, 500 µL of Quicklysis (Cytognos, Salamanca, Spain), a fixative-free red blood cell lysing solution, were added to each tube. 10 min later, the cells were ready for acquisition in the flow cytometer.
Flow cytometry acquisition and data analysis
All samples were acquired immediately after the staining procedure, using a FACS Canto™ II flow cytometer equipped with blue argon (488 nm), red (633 nm) and violet (405 nm) lasers, and the FACS Diva Software (Becton Dickinson, San Jose, USA). The instrument was calibrated using the Euroflow recommendations (https ://www.eurofl ow.org/) and the instrument performance was monitored daily using the Cytometer Setup and tracking beads™ (Becton Dickinson, Franklin Lakes, USA). All tubes were acquired to the end, to recover the maximum number of cells.
Data analysis was performed using the Infinicyt™ software (Cytognos, Salamanca, Spain). Saphenous vein EC were identified as being CD45 neg CD146 bright CD31 bright . Then, the expression of the studied molecules was evaluated by the corresponding mean fluorescence intensity (MFI).
Statistical analysis
It was not possible to perform power analysis and to calculate the sample size needed for the study because there were no previous data concerning the expression of cell surface molecules on the EC of the SV from patients with CVD and from patients submitted to bypass surgery, using this type of approach.
The results were expressed as median, minimum, and maximum values, for continuous quantitative variables, and as absolute and relative frequencies, for categorical variables. The Mann-Whitney U test was used to compare differences between continuous variables of two independent groups. The Chi-square test was used to compare the frequencies of categorical variables between groups. The differences were considered statistically significant for P < 0.05. The statistical analysis was made using the SPSS software (SPSS 20.0., Chicago, IL, USA), while the box plots were made using the Excel 2016 software (Microsoft, Washington, USA).
Results
Using a mechanical method for EC harvesting, a fixativefree immunophenotyping procedure and optimized combinations of mAbs, we were able to clearly identify ECs in cell suspensions obtained from all SV segments studied. In the FSC/SSC dot plot, these cells formed a well-defined cluster above the lymphocyte cluster, and they were CD45 neg CD146 bright CD31 bright (Fig. 2, panel a) . In addition, the EC identified expressed variable levels of other cell surface molecules that are relevant for EC function (Fig. 2, panel b) . These include CD54 (ICAM-1), CD62E (E-Selectin), and CD106 (VCAM-1), all three recognized as activation-related markers; CD142 (tissue factor), a procoagulant molecule; and CD36 (thrombospondin-1 receptor), a scavenger receptor with fatty acid translocase and anti-angiogenic activity involved in lipid metabolism and the immune responses ( Fig. 2, panel b) .
From a median number of 50000 total events analyzed in each tube, ranging from 10000 to 400000, a median number of 7448 events (14.8%), ranging from 517 to 74273, corresponded to EC ( Table 3 ). The percentage of EC recovered from the SV segments was higher in the CVD group than in the group of patients submitted to bypass surgery. The highest values were observed in the distal-VSV, with a median value of 23.5% EC (ranging from 6.5 to 46.5%), followed by the proximal-VSV, with a median value of 10.4% EC (minimum and maximum values of 3.3% and 33.0%, respectively). The proximal-GSV segments were the ones with the lowest percentage of recovered EC (median value of 6.1%, ranging from 0.9 to 19.5%) ( Table 3) .
Concerning the cell size and complexity, the FSC-A and SSC-A of the EC isolated from both the distal-and the proximal-VSV of the CVD patients, were significantly lower than those observed in the EC from the proximal-GSV segments of the control group (P < 0.001), the lowest values being observed in those harvested from the distal-VSV (Fig. 3, panel a) . Differences in EC cell size (FSC-A) and complexity (SSC-A) between CVD patients and controls were statistically significant when males and females were analyzed separately (Online Resource ESM_Table 1). The same was observed when the EC from CVD patients were compared with the EC from subgroups of controls with distinct pathologies: patients with atherosclerosis-related peripheral vascular disease, who account for the majority of cases in the control group (12 patients, 60%), and patients with aneurysms or renal transplant recipients (4 patients in each group, 20%) (Online Resource ESM_Table 2). In contrast, there were no statistically significant differences in the FSC-A and SSC-A of the EC extracted from the proximaland distal-VSV fragments obtained from the patients with CVD (P > 0.05).
When analyzing the MFI of the junction adhesion molecules used to identify the EC, we noticed that the EC from both VSV segments, proximal and distal, had a statistically significant lower CD31 and CD146 expression than the EC from the proximal-GSV (P < 0.001 in both cases) ( Fig. 3,  panel b ). However, the MFI of CD31 and CD146 expression on the EC from the distal-and proximal-VSV of the CVD patients, did not differ significantly from each other (P > 0.05).
Activation-related markers (CD54, CD62E, and CD106), procoagulant molecules (CD142) and scavenger receptors (CD36) (Fig. 3, panel b) , also had lower MFI values in the EC obtained from the distal-VSV segments of patients with CVD, as compared to the EC recovered from the proximal-GSV of patients submitted to bypass surgery (P < 0.001 in all cases) (Fig. 3, panel c) . Similar results were obtained when the EC from the proximal-VSV and -GSV were compared to each other, with differences reaching statistical significance for all markers, except for CD36. And when comparing the EC recovered from the proximal-and distal-VSV from CVD patients, the differences were statistically significant only for CD62E, CD106, CD142, and CD36, whose levels of expression were lower in the distal-VSV segments, Fig. 2 Bivariate dot-plots illustrating the EC identification and characterization for the expression of different cell surface molecules using FCM. Endothelial cells (red dots) stain brightly for CD31 and CD146, they are CD45-negative and they have relatively high FSC-A and SSC-A values (a). Besides being CD45 neg CD146 bright CD31 bright , the EC also show variable levels of expression of activation-related markers (CD54, CD62E, and CD106), procoagulant molecules (CD142), and scavenger receptors (CD36) (b). Residual lymphocytes present in the sample (blue dots) and other cells released from the SV segment by mechanical disaggregation (grey dots) are showed for comparison. (APC allophycocyanin, FCM flow cytometry, FITC fluorescein isothiocyanate, FSC-A forward scatter area, MFI mean fluorescence intensity, PE phycoerythrin, PerCP peridinin chlorophyll protein, SSC-A side scatter area, SV saphenous veins, V450 violet 450) ◂ which were more affected by the disease (P = 0.030, 0.003, 0.014 and < 0.001, respectively). Some of the differences on the expression of the EC surface molecules lose statistical significance when males and females were analyzed separately, probably because of the low number of patients in some of the groups (i.e., only seven males for VSV segments and only five females for GSV segments) (Online Resource, ESM_Table 1). Probably because of the same reason, statistical significance was lost when the EC from CVD patients were compared with the EC from controls with aneurysms or renal transplant recipients (only four patients each), but not when the subgroup of controls having atherosclerosisrelated peripheral vascular disease, who account for the majority of the controls, was considered (Online Resource, ESM_Table 2).
Discussion
As far as we know, our exploratory study is the pioneer in evaluating, by FCM, the immunophenotype of the EC mechanically isolated from the SV in different conditions: patients with CVD submitted to VSV surgery (study group) and patients submitted to bypass surgery using GSV conduits (control group).
Our results revealed lower EC size and complexity, as well as lower expression levels of adhesion (CD31 and CD146), activation-related (CD54, CD62E and CD106), and procoagulant (CD142) molecules, and the scavenger class B receptor CD36, on the EC of both the distal-and proximal-VSV segments of the CVD group in comparison to the EC of the proximal-GVS segments of the control group. In distal-VSV segments, corresponding to varicose trunks, these differences reached statistical significance for all the molecules evaluated, whereas in proximal-VSV, corresponding to vein segments with normal or nearly normal macroscopic features, but physiologically abnormal with venous reflux, differences on the expression of CD36 were not statistically significant.
It may be questioned whether the group we use as control, consisting mainly in patients who performed bypass surgery because of having peripheral arterial disease, is appropriate.
Given that SV segments from normal individuals are not available for research, having CVD was an exclusion criteria for the control group, and the proximal-VSV and the -GSV segments corresponded exactly to the same anatomic region, this option seems to be reasonable. In addition, the mechanism underlying peripheral arterial and venous diseases is distinct [36] . Unfortunately, it was not possible to match groups according to the gender, not to have a uniform group of patients submitted to bypass surgery. To date, no studies have been specifically designed to examine whether gender has impact on the immunophenotype of the EC; however, there are several studies documenting differences between males and females, and hormonal effects in vascular tone and numerous aspects of the EC function [37, 38] . Therefore, we cannot exclude the possibility of having confounder effects. Further research is needed, using larger series of participants, matching patients and controls for the most relevant confounder variables, including gender, and classifying CVD patients according to disease severity, to confirm and extend the results obtained in our exploratory study.
To the best of our knowledge, of the few FCM-based EC studies published to date, only Tisato et al. have compared the expression of cell surface molecules on the EC isolated from the tertiary venous network and/or SV of CVD patients [39] . Unlike us, the authors found that EC from CVD patients had significantly higher expression of CD31, CD146, and CD54 as compared to control EC, and they did not detect CD106 expression on the EC in none of the groups. Differences may be explained by the experimental conditions, as Tisato et al. have used EC isolated by an enzymatic method, followed by seeding them in cell culture; in addition, the control group consisted of commercially available EC [39] .
There is no agreement on the best method to isolate the EC, which probably depends on the type and caliber of the vessels, as well as on the study purpose [40] . Enzymatic digestion is one of the preferred techniques for large vessels, e.g., HUVEC and SV. Its advantages include a good yield and a high purity, with low contamination by other cells; a major disadvantage is that the enzymes may exert detrimental effects on cell surface receptors. Mechanical scraping, either manually or using commercialized devices, is suitable for both macro-and micro-vessels; advantages of this approach are high purity and lower damage to EC, whereas a low yield is a disadvantage. For instance, it is well known that proteolytic enzymes may not only disrupt and diminish the cells surface receptors, as they can modify the conformation of the cell surface molecules and cell structures [34, [40] [41] [42] . In accordance, when comparing the effects of mechanical and different enzymatic disaggregation methods, Grange et al. found that the first method does not induce changes in the cell surface receptors, unlike the enzymatic treatment which provokes a decrease in surface cell markers; the mortality induced by these methods was very similar [41] . Moreover, the enzymatic method, although exhibiting higher yield of EC cells, is accompanied by the released of unwanted cells, such as fibroblasts and smooth muscle cells [40, 43] . It is also important to mention that the use of enzymes requires several cautions because each type of enzyme acts at different molecular level, affecting different structures and functions of the cells [41, 42, 44] .
Finally, but not least, the enzymatic method requires subsequent cell culture, which may also cause functional and morphologic alterations in the EC [40, 45] . Unlike the mechanical method, both these steps, enzymatic isolation and cell culture, determine modifications of the EC phenotype, not depicting the cells in the original condition of their native environment. For the reasons mentioned previously and taking in consideration this is an immunophenotyping-based study, we harvested the EC from the SV segments using a mechanical approach. At that point, it should be important to note that, although we had a low yield of EC in some SV segments, due to their small length, we always obtained a well-defined cluster of EC that allowed us to appropriately identify and characterize them by FCM. In immunohistochemistry studies, there is also a lack of consensus concerning the expression of different activation-related markers on the SV biopsies obtained from patients with CVD. One possible reason is that chemical products and fixatives may have a profound impact in antigenicity [46] . In one study there were no statistically significant differences on the expression of CD54 (ICAM-1) nor CD106 (VCAM-1), as compared to the EC of SV segments used for bypass [47] . In other study, Takase et al. reported that the expression of CD54 (ICAM-1) on the surface of the luminal endothelium of proximal VSV segments tended to be higher relative to the EC derived from the distal SV segments used for bypass, but they did not find differences on the expression of the CD62E (E-selectin) [48] . While, Ghaderian et al. observed the expression of CD54 (ICAM-1) on the EC in only 2 out of 20 VV segments, and no expression of CD62E; concerning the EC of SV segments used for bypass, none of these molecules were found to be expressed [49] . Supporting part of our findings, the study performed by Surendran et al., based also on immunohistochemistry, revealed a lower CD31 expression on the EC from the SV obtained from CVD patients, in comparison to that observed on EC from SV segments used for coronary artery bypass [50] . We used a fixative-free solution for red blood cell lysing, to avoid the effects of chemical products and fixatives on the EC.
Hemodynamic alterations on the blood flow, such as blood stasis and turbulence, hypoxia and venous hypertension, are trigger events for the development of CVD. All these conditions, which are interrelated, may contribute to a cascade of biologic events inducing several structural and biochemical alterations in the vein wall (for review see [1, 51, 52] ). They activate the endothelium, promoting the adhesion and migration of the leukocytes through the EC layer, and inducing the release of growth factors, inflammatory mediators, reactive oxygen species and proteolytic enzymes either derived from leukocytes as from the EC and compromising the vessel wall integrity [53] [54] [55] . A major consequence is the increase of the vascular permeability, where we speculate that may be due to a decrease of the intercellular junction adhesion molecules, at the surface of the EC. In accordance, we found lower levels of CD31 and the CD146 expression on the EC harvested from the VSV of the CVD patients, with distal and more profoundly affected VSV segments having the lowest levels of CD31 and CD146 expression. Also in agreement, in vitro studies have shown that either the knockdown of the CD31 gene, the use of a blocking anti-CD31 mAb as the transfection of cell lines with CD31 and CD146, were able to induce an increase of the endothelial barrier permeability [56] [57] [58] . In vitro experiments have also revealed that HUVEC exposed to stasis and to the effect of the Vascular Endothelial Growth Factor, which are conditions in which the SV of the patients with CVD are repeatedly subjected, display a downregulation of the expression of the CD36 [30] .
The reasons for a decreased expression of several cell surface molecules on the EC obtained from the VSV of patients with CVD are unknown. Several works have shown that matrix metalloproteinases not only contribute for the degradation of the ECM and for the imbalance of the collagen and elastin ratio but also may cleave the cell surface receptors releasing them for the bloodstream [59, 60] . In accordance, increased levels of EC molecules, such as CD54, CD106, and CD62E, have been described in the plasma obtained from the lower limbs of the CVD patients exposed to hypertension, stasis and VV surgery [24, 59, 61] . Maybe this is one of the mechanisms accounting for the diminished expression of these molecules on the EC. In the future, it will be important to complement FCM data with EC-soluble markers, as already done by other authors [62, 63] , and to evaluate the nitric oxide synthase, which seems to be diminished in CVD, contributing to the presence of the endothelial dysfunction [64] .
Electron microscopy studies have revealed a disorganized intima layer in the VSV, with abnormally shaped EC with irregular borders, nucleus margination, cytoplasm vacuoles, and mitochondrial degeneration; all these changes may account for variations on the EC shape, granularity and autofluorescence [12, 20, 34, 65, 66] . Wali et al. found that these changes revealing the endothelial damage were higher in the distal VSV segments than in the proximal ones [20] . The ECM, which maintains the tissue structure, has been reported to be degraded in the VSV of patients with CVD [12, 15, 20, 66] . The hemodynamic forces also cause morphological changes on the EC, and stasis and disturbed flow may affect the size of the cells, converting the elongated cells into round ones [67, 68] . Overall, these alterations may explain not only the lower cell size and complexity but also an easier detachment of the EC from the VSV, especially in the most affected distal segments.
Although we did not look for the expression of apoptosis markers on the EC, other studies have suggested a downregulation of the programmed cell death in the VV [69] [70] [71] . One of these studies found that the apoptotic rate was lower in the distal SV segments, as compared to the proximal great SV [69] . This suggests that the EC from the VV do not have the capability to restore and/or maintain the vascular integrity, which may be also one of the reasons that we had lower expression of the cell surface molecules on the EC isolated from both VSV segments of the patients with CVD, especially in the distal ones.
The effects mentioned previously may be due to the secondary action of proteolytic enzymes, downregulation of apoptosis and biochemical and structural changes of the EC exposed to trigger events, inducing their dysfunctionality and decreasing their responsiveness to noxious stimuli and/ or to a primary EC defect in patients suffering from CVD. In fact, some have identified genetic markers in patients with VV, suggesting a genetic basis for CVD [72, 73] . Some examples are the presence of the c.512C > T polymorphism, which may trigger an altered FoxC2-Notch signalling cascade, resulting in remodelling of SV in patients with CVD [72] , and the del TT allele mutation of thrombomodulin, an EC receptor for thrombin [73] .
In conclusion, our fixative-and enzyme-free FCM study suggests that at some point during the course of CVD, the disease affects the EC morphology and diminishes the levels of expression of several cell surface receptors, which may contribute to the EC dysfunction and unresponsiveness to stimuli. Whether these EC changes are cause or consequence of the disease, and how much they contribute for the appearance and/or evolution of CVD remain an open question, and the underlying molecular mechanisms are unknown. Fig. 3 Light scatter characteristics and MFI expression of the junctional (CD31 and CD146), activation-related (CD54, CD62E, and CD106), the procoagulant molecule, CD142, and the scavenger class B receptor CD36, on the EC isolated from the distal-and proximal-VSV segments (CVD group) and from the proximal-GSV segments (control group). Box plots showing the light scatter characteristic (SSC-A and FCS-A) (a), and the MFI values of CD45, CD31, and CD146 (b), activation-related (CD54, CD62E, and CD106), procoagulant molecules (CD142) and scavenger receptors (CD36) (c), of the EC extracted from the proximal-(blue boxes) and distal-(orange boxes) VSV segments from patients with CVD submitted to VV surgery, and from the proximal-GSV segments from patients submitted to bypass surgery (grey boxes). The box lower and upper limits represent the 1st and 3rd quartiles, respectively. Inside the box, the x corresponds to the mean, and the line in the middle represents the median. The lower and upper limits of the whiskers represent the minimum and maximum values, respectively, and the points above the whisker correspond to the outliers. P values were calculated using the Mann-Whitney U test. P < 0.05 was considered statistically significant. (APC allophycocyanin, Distal-VSV distal varicose saphenous veins, i.e., trunk varicose vein segments, EC endothelial cell, FITC fluorescein isothiocyanate, FSC-A forward scatter area, GSV graft saphenous veins, MFI mean fluorescence intensity, PE phycoerythrin; PerCP, peridinin chlorophyll protein, Proximal-GSV proximal graft saphenous veins, Proximal-VSV proximal varicose saphenous veins, SSC-A side scatter area; V450, violet 450, VSV varicose saphenous veins, VV varicose veins) ◂
